A novel doxorubicin-glucuronide prodrug DOX-GA3 for tumour-selective chemotherapy: distribution and efficacy in experimental human ovarian cancer

The doxorubicin (DOX) prodrug N -[4-doxorubicin- N -carbonyl (oxymethyl) phenyl] O -β-glucuronyl carbamate (DOX-GA3) was synthesised for specific activation by human β-glucuronidase, which is released in necrotic areas of tumour lesions. This novel prodrug was completely activated to the parent drug...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Houba, P H J, Boven, E, Meulen-Muileman, I H van der, Leenders, R G G, Scheeren, J W, Pinedo, H M, Haisma, H J
פורמט: Artigo
שפה:Inglês
יצא לאור: Nature Publishing Group 2001
נושאים:
Regular Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC2363760/
https://ncbi.nlm.nih.gov/pubmed/11207053
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1054/bjoc.2000.1640
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים